LAUREN YANALUNAS: Open Payments
NPI 1407493935 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 22 payments from 10 companies in 2025. Trend: 2023 $1,003 · 2024 $60 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $144 |
| ABBVIE INC. | 6 | $121 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: DAXXIFY, Auvelity, VRAYLAR, Kerendia, QULIPTA, NUZYRA, BOTOX, FUROSCIX.
Industry payments across MI — which companies pay providers there.
